DRUG · Unmapped registry intervention
RBP-7000
Find medicine records ·
Find other trials using this name
Clinical trial
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
NCT02109562
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Risperidone
Normalized identity: risperidoneView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedRandomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Interventions
Sponsors & collaborators
Indivior Inc.lead sponsor
Mapped research locations
DallasTexas, United States2St LouisMissouri, United States2AustinTexas, United States2Long BeachCalifornia, United States2ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1San DiegoCalifornia, United States1OrlandoFlorida, United States1Oklahoma CityOklahoma, United States1Las VegasNevada, United States1CharlotteNorth Carolina, United States1Little RockArkansas, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02109562 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.